Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published by: Global Markets Direct

Published: Jan. 31, 2009 - 94 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Drug delivery devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry powder inhaler
3.3 Infusion Systems
3.3.1 Infusion pumps
3.3.2 Syringe pumps
3.3.3 Disposable Infusion sets
3.4 Needle-free Injections
4 Drug Delivery Devices in North America
4.1 Drug Delivery Devices Cross Country Comparison (2000-2012)
4.2 Drug Delivery Devices, North America, Overall Revenues ($ mn), 2000-2012
4.3 Drug Delivery Devices, North America, Company Share (2006-2007)
5 Drug Delivery Devices In United States
5.1 Drug Delivery Devices, United States, Overall Revenues ($ mn), 2000-2012
5.2 Drug Delivery Devices, United States, Category Volume (Units), 2000-2012
5.3 Drug Delivery Devices, United States, Distribution Share (2006-2007)
5.3.1 Infusion Systems Distribution Share (2006-2007)
5.3.2 Inhalation Systems Distribution Share (2006-2007)
5.3.3 Needle Free Injections Distribution Share (2006-2007)
5.4 Drug Delivery Devices, United States, Company Share (2006-2007)
5.4.1 Drug Delivery Devices, United States, Company Share (2006-2007)
5.4.2 Infusion Systems, United States, Company Share (2006-2007)
5.4.3 Inhalation Systems, United States, Company Share (2006-2007)
5.4.4 Needle Free Injections, United States, Company Share (2006-2007)
6 Drug Delivery Devices In Canada
6.1 Drug Delivery Devices, Canada, Overall Revenues ($ mn), 2000-2012
6.2 Drug Delivery Devices, Canada, Category Volume (Units), 2000-2012
6.3 Drug Delivery Devices, Canada, Distribution Share (2006-2007)
6.3.1 Infusion Systems Distribution Share (2006-2007)
6.3.2 Inhalation Systems Distribution Share (2006-2007)
6.3.3 Needle Free Injections Distribution Share (2006-2007)
6.4 Drug Delivery Devices, Canada, Company Share (2006-2007)
6.4.1 Drug Delivery Devices, Canada, Company Share (2006-2007)
6.4.2 Infusion Systems, Canada, Company Share (2006-2007)
6.4.3 Inhalation Systems, Canada, Company Share (2006-2007)
6.4.4 Needle Free Injections, Canada, Company Share (2006-2007)
7 AstraZeneca PLC Company Profile
7.1 Company Overview
8 GlaxoSmithKline plc Company Profile
8.1 Company Overview
9 Cardinal Health, Inc. Company Profile
9.1 Company Overview
9.2 Value Chain Analysis
9.2.1 Manufacturing
9.2.1.1 In House Manufacturing
9.2.1.2 Outsourcing
9.2.2 Product Development
9.2.2.1 Regulatory Approvals
9.2.2.2 Research and Development
9.2.3 Sales and Marketing
9.2.3.1 Partnerships and Alliances
9.2.3.2 Licensing Agreements
10 3M Company Company Profile
10.1 Company Overview
10.2 Value Chain Analysis
10.2.1 Manufacturing
10.2.1.1 In House Manufacturing
10.2.2 Product Development
10.2.2.1 Regulatory Approvals
10.2.2.2 Clinical Trials
10.2.2.3 Research and Development
10.2.3 Sales and Marketing
10.2.3.1 Partnerships and Alliances
10.2.3.2 Licensing Agreements
10.2.3.3 E-distribution
11 Baxter International Inc. Company Profile
11.1 Company Overview
11.2 Value Chain Analysis
11.2.1 Manufacturing
11.2.1.1 In House Manufacturing
11.2.2 Product Development
11.2.2.1 Regulatory Approvals
11.2.2.2 Clinical Trials
11.2.2.3 Research and Development
11.2.3 Sales and Marketing
11.2.3.1 Partnerships and Alliances
11.2.3.2 Licensing Agreements
11.2.3.3 E-distribution
11.3 Baxter International Inc. Pipeline Products
11.3.1 Baxter International Inc. Pipeline Products By Equipment Type
11.3.2 Baxter International Inc. Pipeline Products By Development Stage
11.3.3 Baxter International Inc. Pipeline Products By Therapy Area
11.3.4 Baxter International Inc. Pipeline Products By Clinical Trials
11.3.5 Baxter International Inc. Pipeline Products By News Summary
12 Hospira, Inc. Company Profile
12.1 Company Overview
12.2 Value Chain Analysis
12.2.1 Manufacturing
12.2.1.1 In House Manufacturing
12.2.1.2 Outsourcing
12.2.2 Product Development
12.2.2.1 Regulatory Approvals
12.2.2.2 Clinical Trials
12.2.2.3 Research and Development
12.2.3 Sales and Marketing
12.2.3.1 Partnerships and Alliances
12.2.3.2 E-distribution
13 Boehringer Ingelheim GmbH Company Profile
13.1 Company Overview
13.2 Value Chain Analysis
13.2.1 Manufacturing
13.2.1.1 In House Manufacturing
13.2.1.2 Outsourcing
13.2.2 Product Development
13.2.2.1 Regulatory Approvals
13.2.2.2 Clinical Trials
13.2.2.3 Research and Development
13.2.3 Sales and Marketing
13.2.3.1 Licensing Agreements
13.2.3.2 Partnerships and Alliances
14 AKELA Pharma Inc. Company Profile
14.1 Company Overview
14.2 AKELA Pharma Inc. Pipeline Products
14.2.1 AKELA Pharma Inc. Pipeline Products By Equipment Type
14.2.2 AKELA Pharma Inc. Pipeline Products By Development Stage
14.2.3 AKELA Pharma Inc. Pipeline Products By Therapy Area
14.2.4 AKELA Pharma Inc. Pipeline Products By News Summary
15 Bioject Medical Technologies Inc. Company Profile
15.1 Company Overview
15.2 Value Chain Analysis
15.2.1 Manufacturing
15.2.1.1 In House Manufacturing
15.2.1.2 Outsourcing
15.2.2 Product Development
15.2.2.1 Regulatory Approvals
15.2.2.2 Clinical Trials
15.2.2.3 Research and Development
15.2.3 Sales and Marketing
15.2.3.1 Partnerships and Alliances
15.2.3.2 Licensing Agreements
15.3 Bioject Medical Technologies Inc. Pipeline Products
15.3.1 Bioject Medical Technologies Inc. Pipeline Products By Equipment Type
15.3.2 Bioject Medical Technologies Inc. Pipeline Products By Development Stage
15.3.3 Bioject Medical Technologies Inc. Pipeline Products By Therapy Area
15.3.4 Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials
15.3.5 Bioject Medical Technologies Inc. Pipeline Products By News Summary
16 Corium International, Inc. Company Profile
16.1 Company Overview
16.2 Corium International, Inc. Pipeline Products
16.2.1 Corium International, Inc. Pipeline Products By Equipment Type
16.2.2 Corium International, Inc. Pipeline Products By Development Stage
16.2.3 Corium International, Inc. Pipeline Products By Therapy Area
16.2.4 Corium International, Inc. Pipeline Products By News Summary
17 Inyx, Inc. Company Profile
17.1 Company Overview
18 Oriel Therapeutics Inc. Company Profile
18.1 Company Overview
19 TheraJect, Inc. Company Profile
19.1 Company Overview
19.2 TheraJect, Inc. Pipeline Products
19.2.1 TheraJect, Inc. Pipeline Products By Equipment Type
19.2.2 TheraJect, Inc. Pipeline Products By Development Stage
19.2.3 TheraJect, Inc. Pipeline Products By Therapy Area
19.2.4 TheraJect, Inc. Pipeline Products By Clinical Trials
20 Ventaira Pharmaceuticals, Inc. Company Profile
20.1 Company Overview
21 Verus Pharmaceuticals, Inc. Company Profile
21.1 Company Overview
22 Wolfe Tory Medical, Inc. Company Profile
22.1 Company Overview
23 Zogenix, Inc. Company Profile
23.1 Company Overview
23.2 Zogenix, Inc. Pipeline Products
23.2.1 Zogenix, Inc. Pipeline Products By Equipment Type
23.2.2 Zogenix, Inc. Pipeline Products By Development Stage
23.2.3 Zogenix, Inc. Pipeline Products By Therapy Area
23.2.4 Zogenix, Inc. Pipeline Products By Clinical Trials
23.2.5 Zogenix, Inc. Pipeline Products By News Summary
24 Financial Deals Landscape
24.1 Acquisition
24.2 Partnerships
25 Recent Developments
25.1 Product News
25.1.1 Dec 09, 2008: Zosano Pharma Announces Zosano Pharma, Inc. Completes Positive End-Of-Phase 2 Meeting With FDA Regarding ZP- PTH Patch For Osteoporosis
25.1.2 Dec 04, 2008: FlowMedica Receives FDA Clearance For New Indication For The Benephit Infusion Systems
25.1.3 Nov 26, 2008: Milestone Scientific To Showcase STA System At The Greater New York Dental Meeting In New York City
25.1.4 Nov 20, 2008: Trellis Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
25.1.5 Nov 03, 2008: Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial Of Epodure In Renal Anemia
25.1.6 Oct 23, 2008: Zosano Pharma To Present At Bio Investor Forum
25.1.7 Oct 15, 2008: Lilly Launches New FORTEO Delivery Device
25.1.8 Oct 14, 2008: Milestone Scientific To Showcase STA System At The American Dental Association Annual Session
26 APPENDIX
26.1 Global Markets Direct Research Methodology
26.2 Coverage
26.3 Secondary Research
26.4 Primary Research
26.5 Models
26.6 Forecasts
26.7 Expert Panels
26.8 Currency Conversion
26.9 Contact Us
26.10 Disclaimer
1.1 List of Tables
Table 1: Drug Delivery Devices Cross Country Comparison (2000-2012)
Table 2: Drug Delivery Devices, North America, Overall Revenues ($ mn), 2000-2012
Table 3: Drug Delivery Devices, North America, Overall Revenues ($ mn), 2000-2012
Table 4: Drug Delivery Devices, North America, Overall Revenues ($ mn), Historic, 2000-2007
Table 5: Drug Delivery Devices, North America, Overall Revenues ($ mn), Forecast, 2007-2012
Table 6: Drug Delivery Devices, North America, Company Share by Revenue ($ mn), 2006-2007
Table 7: Drug Delivery Devices, United States, Overall Revenues ($ mn), 2000-2012
Table 8: Drug Delivery Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
Table 9: Drug Delivery Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Table 10: Drug Delivery Devices, United States, Category Volume (Units), 2000-2012
Table 11: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2007
Table 12: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2007-2012
Table 13: Infusion Systems, United States, Distribution Share by Revenue ($mn), 2006-2007
Table 14: Inhalation Systems, United States, Distribution Share by Revenue ($mn), 2006-2007
Table 15: Needle Free Injections, United States, Distribution Share by Revenue ($mn), 2006-2007
Table 16: Drug Delivery Devices, United States, Company Share by Revenue ($ mn), 2006-2007
Table 17: Infusion Systems, United States, Company Share by Revenue ($ mn), 2006-2007
Table 18: Inhalation Systems, United States, Company Share by Revenue ($ mn), 2006-2007
Table 19: Needle Free Injections, United States, Company Share by Revenue ($ mn), 2006-2007
Table 20: Drug Delivery Devices, Canada, Overall Revenues ($ mn), 2000-2012
Table 21: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
Table 22: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
Table 23: Drug Delivery Devices, Canada, Category Volume (Units), 2000-2012
Table 24: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2000-2007
Table 25: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2007-2012
Table 26: Infusion Systems, Canada, Distribution Share by Revenue ($mn), 2006-2007
Table 27: Inhalation Systems, Canada, Distribution Share by Revenue ($mn), 2006-2007
Table 28: Needle Free Injections, Canada, Distribution Share by Revenue ($mn), 2006-2007
Table 29: Drug Delivery Devices, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 30: Infusion Systems, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 31: Inhalation Systems, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 32: Needle Free Injections, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 33: Baxter International Inc. Pipeline Products by Equipment Type
Table 34: Baxter International Inc. Pipeline Products By Development Stage
Table 35: Baxter International Inc. Pipeline Products By Therapy Area
Table 36: Baxter International Inc. Pipeline Products By Clinical Trials
Table 37: Baxter International Inc. Pipeline Products By News Summaries
Table 38: AKELA Pharma Inc. Pipeline Products by Equipment Type
Table 39: AKELA Pharma Inc. Pipeline Products By Development Stage
Table 40: AKELA Pharma Inc. Pipeline Products By Therapy Area
Table 41: AKELA Pharma Inc. Pipeline Products By News Summaries
Table 42: Bioject Medical Technologies Inc. Pipeline Products by Equipment Type
Table 43: Bioject Medical Technologies Inc. Pipeline Products By Development Stage
Table 44: Bioject Medical Technologies Inc. Pipeline Products By Therapy Area
Table 45: Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials
Table 46: Bioject Medical Technologies Inc. Pipeline Products By News Summaries
Table 47: Corium International, Inc. Pipeline Products by Equipment Type
Table 48: Corium International, Inc. Pipeline Products By Development Stage
Table 49: Corium International, Inc. Pipeline Products By Therapy Area
Table 50: Corium International, Inc. Pipeline Products By News Summaries
Table 51: TheraJect, Inc. Pipeline Products by Equipment Type
Table 52: TheraJect, Inc. Pipeline Products By Development Stage
Table 53: TheraJect, Inc. Pipeline Products By Therapy Area
Table 54: TheraJect, Inc. Pipeline Products By Clinical Trials
Table 55: Zogenix, Inc. Pipeline Products by Equipment Type
Table 56: Zogenix, Inc. Pipeline Products By Development Stage
Table 57: Zogenix, Inc. Pipeline Products By Therapy Area
Table 58: Zogenix, Inc. Pipeline Products By Clinical Trials
Table 59: Zogenix, Inc. Pipeline Products By News Summaries
Table 60: Nicholas Piramal India To Acquire MINRAD INTERNATIONAL
Table 61: Covidien Enters Into An Agreement With Depomed
Table 62: MonoSol Enters Into An Agreement With Midatech
Table 63: Acusphere Enters Into An Agreement With Cephalon
Table 64: Stallergenes Enters Into An Agreement With Catalent Pharma Solutions And The Medical House
Table 65: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures
Figure 1: Drug Delivery Devices Cross Country Comparison (2000-2012)
Figure 2: Drug Delivery Devices, North America, Overall Revenues ($ mn), 2000-2012
Figure 3: Drug Delivery Devices, North America, Portfolio Analysis, 2000-2012
Figure 4: Drug Delivery Devices, North America, Overall Revenues ($ mn), Historic, 2000-2007
Figure 5: Drug Delivery Devices, North America, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 6: Drug Delivery Devices, North America, Company Share (%), 2007
Figure 7: Drug Delivery Devices, United States, Overall Revenues ($ mn), 2000-2012
Figure 8: Drug Delivery Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
Figure 9: Drug Delivery Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 10: Drug Delivery Devices, United States, Category Volume (Units), 2000-2012
Figure 11: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2007
Figure 12: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2007-2012
Figure 13: Drug Delivery Devices, United States, Company Share (%), 2007
Figure 14: Infusion Systems, United States, Company Share (%), 2007
Figure 15: Inhalation Systems, United States, Company Share (%), 2007
Figure 16: Needle Free Injections, United States, Company Share (%), 2007
Figure 17: Drug Delivery Devices, Canada, Overall Revenues ($ mn), 2000-2012
Figure 18: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
Figure 19: Drug Delivery Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 20: Drug Delivery Devices, Canada, Category Volume (Units), 2000-2012
Figure 21: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2000-2007
Figure 22: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2007-2012
Figure 23: Drug Delivery Devices, Canada, Company Share (%), 2007
Figure 24: Infusion Systems, Canada, Company Share (%), 2007
Figure 25: Inhalation Systems, Canada, Company Share (%), 2007
Figure 26: Needle Free Injections, Canada, Company Share (%), 2007
Figure 27: Cardinal Health, Inc. Value Chain Analysis
Figure 28: 3M Healthcare Value Chain Analysis
Figure 29: Baxter International Inc. Value Chain Analysis
Figure 30: Hospira, Inc. Value Chain Analysis
Figure 31: Boehringer Ingelheim GmbH Value Chain Analysis
Figure 32: Bioject Medical Technologies Inc. Value Chain Analysis
Figure 33: Global Markets Direct Methodology

Abstract

North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to North America drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in North America

Scope
  • The report provides drug delivery devices information broken down into detailed categories in North America.
  • Total revenues, products sold and end users.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the drug delivery devices market in North America.
  • Evaluate and compare the attractiveness of the market in the region.
  • Identify growth segments and opportunities in each industry sector within the region.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
  • Analyze the competitiveness of the market in the region and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the region.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the region.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009